Intertek Acquires QTI

June 7, 2007: Houston USA, London UK - Intertek Group plc (Intertek), a leading international provider of quality and safety services to a wide range of industries, has acquired Quantitative Technologies Inc (QTI). QTI will operate in the Intertek OCA Division (Caleb Brett) Pharmaceutical Services group.

QTI is a leading a contract analytical research and development laboratory that has been serving the pharmaceutical, medical device and drug delivery industry in North America for over 15 years, specialising in the pre-market launch stages of the drug and product development life cycle. QTI is located in Whitehouse, New Jersey with approximately 60 staff and counts major global pharmaceutical companies among its clients. The laboratory is highly regarded for technical expertise, rigorous compliance programs, and outstanding customer service – it is a current Good Manufacturing Practice (cGMP) facility in good standing with the US Food and Drug Administration (FDA).

The acquisition further advances Intertek’s strategic growth in expert support services to the global pharmaceutical, medical device and drug delivery industry through the provision of state of the art analytical services.

CEO of Intertek’s OCA Division (Caleb Brett), Mark Loughead, comments; “QTI has an outstanding reputation in the industry and will further expand our ability to support the pharmaceutical and related sectors for outsourced R&D and testing expertise."

John Conti-Ramsden, PhD, global director for Intertek Pharmaceutical Services, said; "The acquisition of QTI further develops Intertek’s USA offering and global platform in the area of pharmaceutical services. Intertek already provides a wide range of testing services to pharmaceutical clients from its laboratories in Europe and Good Laboratory Practice (GLP) bio-analytical services from the Alta laboratories in California.”

Paul Winslow, PhD, managing director of QTI comments; “Joining Intertek provides QTI a global network to access and serve the worldwide pharmaceutical industry. Additionally, Intertek’s commitment to growth will allow QTI to expand our capabilities to provide a more comprehensive service offering to our clients and key industry markets.”

About Intertek:

Intertek Group plc (FTSE: ITRK) is a leading international provider of quality and safety services to a wide range of global and local industries. Partnership with Intertek brings increased value to customers’ products and processes, ultimately supporting their success in the global market place. Intertek has the experience, expertise, resources and global reach to support its customers through their network of 930 laboratories and offices, 18,000 people in 109 countries around the world.

www.intertek.com

About Intertek Pharmaceutical Services:

Intertek’s Pharmaceutical and Speciality Chemical Laboratories provide a wide range of routine and non-routine laboratory testing services to support pharmaceutical, biotechnology and nanotechnology clients. A growing international network of Intertek laboratories and offices serve clients from a wide range of industries on a global basis with services including laboratory testing, outsourcing, inspection, R&D and process services. Intertek laboratories are ideally suited to support a diverse range of fine chemical, pharmaceutical and biotech activities.

www.intertek-cb.com/pharma

Intertek Contacts:
USA: Paul Winslow, Ph.D.
Managing Director for QTI
Telephone +01-908-534-4445
pwinslow@qtionline.com
www.qtionline.com

UK: John Conti-Ramsden, Ph.D.
Director Intertek Pharmaceutical Services
Intertek Pharmaceutical Services
Telephone +44 (0) 161-721-2236
john.conti-ramsden@intertek.com
www.intertek-cb.com/pharma


Intertek: Erik Holladay, Global Marketing Director
Intertek OCA Division (Caleb Brett)
Telephone: +01-713-407-3500 (USA)
testingservices@intertek.com
www.intertek-cb.com
www.intertek.com